论文部分内容阅读
朱冰梅,日本山梨医科大学医学博士,江苏省首批特聘教授,博士生导师。回国前为美国国立卫生研究院(NIH)研究员,现任南京中医药大学针药结合省部共建教育部重点实验室副主任。主要运用高通量测序及其他分子生物学手段揭示中医药防治疾病、针药结合增效减毒的分子及表观遗传学机制。自2011年回国以来先后主持国家973计划子课题、国家自然科学基金、教育部博士点基金、江苏省“双创”人才项目、江苏省“六大人才高峰”计划及省重大基础研究
Zhu Bingmei, Japan Yamanashi Medical University, MD, Jiangsu Province, the first batch of Distinguished Professor, doctoral tutor. Before returning to the United States National Institutes of Health (NIH) researcher, the current Nanjing University of Traditional Chinese Medicine acupuncture combined with the Ministry of Education Key Laboratory of Ministry of Education deputy director. The main use of high-throughput sequencing and other molecular biology means to reveal the prevention and treatment of traditional Chinese medicine disease, acupuncture and medicine combined with synergistic and attenuated molecular and epigenetic mechanisms. Since returning to China in 2011, he has successively presided over the national 973 plan sub-project, the National Natural Science Foundation of China, the Ministry of Education Doctoral Fund, Jiangsu Province, “double create” talent project, Jiangsu Province, “six talents peak” plan and provincial major foundation the study